AndroGel Makers, Buyers Clash Over FTC Getting Discovery
Pharmaceutical companies scolded plaintiffs waging an antitrust fight over testosterone treatment AndroGel for asking a Pennsylvania federal court to let them share sensitive records obtained through discovery with the Federal Trade Commission....To view the full article, register now.
Already a subscriber? Click here to view full article